Downing J, Guttridge M G, Thompson J, Darke C
Welsh Transplantation and Immunogenetics Laboratory, Welsh Blood Service, Pontyclun, Cardiff, Wales, UK.
Genet Test. 2004 Fall;8(3):301-12. doi: 10.1089/gte.2004.8.301.
We have developed a strategy for five-locus human leukocyte antigen (HLA) typing of hematopoeitic stem cell (HSC) donors using the polymerase chain reaction with sequence-specific primers (PCR-SSP). The PCR-SSP method is robust, reproducible, and accurate. New PCR-SSP mixtures can be added as required and all reactions are carried out under the same conditions, which can easily be applied to the typing of other loci, e.g., ABO blood groups. Initially, 127 PCR-SSP reactions were used to detect simultaneously HLA-A, -B, -C, -DRB1/3/4/5, and DQB1 alleles, differentiated generally to the level of the first two digits of the allele name, essentially equivalent to the serological split specificity. Approximately 40% of subjects were tested against a further 29 HLA-A, -B SSP mixtures to exclude rare alleles and unambiguously assign a two-digit HLA allele family. This gave an overall typing resolution equivalent to or greater than the split specificity level and covered all HLA-A, -B, -C, -DRBland DQB1 alleles listed in the WHO's Nomenclature for Factors of the HLA System, 2000. The Welsh Bone Marrow Donor Registry has used this strategy to HLA type over 35,000 HSC donors over 9 years. Comprehensive and accurate five-locus HLA typing allows confident and rapid identification of potential matched HSC donors for patients requiring stem cell transplantation generally without the need for typing additional loci. This allows resources to be focused directly on allele level typing of DRB1 and other loci. This strategy decreases overall donor work-up time, which is a major benefit to patients.
我们开发了一种利用序列特异性引物聚合酶链反应(PCR-SSP)对造血干细胞(HSC)供体进行五位点人类白细胞抗原(HLA)分型的策略。PCR-SSP方法稳健、可重复且准确。可根据需要添加新的PCR-SSP混合物,并且所有反应均在相同条件下进行,这可以轻松应用于其他位点的分型,例如ABO血型。最初,使用127个PCR-SSP反应同时检测HLA-A、-B、-C、-DRB1/3/4/5和DQB1等位基因,一般区分到等位基因名称的前两位水平,基本等同于血清学分型特异性。大约40%的受试者针对另外29种HLA-A、-B SSP混合物进行检测,以排除罕见等位基因并明确指定一个两位的HLA等位基因家族。这使得总体分型分辨率等同于或高于分型特异性水平,并涵盖了世界卫生组织2000年HLA系统因子命名法中列出的所有HLA-A、-B、-C、-DRB和DQB1等位基因。威尔士骨髓供体登记处已使用该策略在9年多的时间里对超过35000名HSC供体进行了HLA分型。全面准确的五位点HLA分型能够可靠且快速地识别出适合一般需要干细胞移植患者的潜在匹配HSC供体,通常无需对其他位点进行分型。这使得资源能够直接集中于DRB1和其他位点的等位基因水平分型。该策略减少了总体供体检查时间,这对患者来说是一个主要益处。